As of 11:17am ET
| +0.08 / +1.96%|
The 1 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +20.19% increase from the last price of 4.16.
The current consensus among 3 polled investment analysts is to Hold stock in Sunesis Pharmaceuticals Inc. This rating has held steady since March, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.